How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses

NCT ID: NCT07121010

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn how different protein types affect the body's metabolism and immune system in healthy adults. The main questions it aims to answer are:

Does drinking smoothies with animal-based or plant-based protein change the level of amino acids like leucine in the blood?

Does adding leucine to a plant-based smoothie make the body respond like it does to an animal-based smoothie?

Participants will:

Come to the research clinic for 3 study visits

Drink a high-protein smoothie at each visit (one with animal protein, one with plant protein, and one with plant protein + leucine)

Give blood samples before and 1 and 3 hours after each smoothie

Researchers will look at how the body's metabolism and immune system respond. They are especially interested in a pathway called mTOR, which helps control how cells use nutrients and may be involved in heart disease like atherosclerosis.

All smoothies are prepared to meet Halal and Kosher dietary guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized, controlled, crossover clinical trial designed to investigate the acute effects of dietary protein source and leucine supplementation on circulating amino acids and downstream metabolic and immune signaling pathways in healthy adults. The study is being conducted by researchers at the University of Pittsburgh and is based on emerging evidence that dietary protein composition-particularly the type and amount of amino acids such as leucine-may influence key biological processes associated with cardiometabolic health.

Proteins are an essential part of the human diet, and different protein sources (plant vs. animal) contain varying amounts and types of amino acids. One amino acid of particular interest is leucine, a branched-chain amino acid (BCAA) known to activate the mTOR (mechanistic target of rapamycin) signaling pathway. The mTOR pathway plays a critical role in regulating cell growth, metabolism, immune responses, and energy use. Excessive or chronic activation of this pathway has been implicated in cardiometabolic diseases, including atherosclerosis, obesity, insulin resistance, and inflammation.

Animal-derived proteins such as milk or meat tend to be richer in leucine than plant-derived proteins like soy or pea protein. This difference may explain some of the metabolic disparities observed between diets high in animal protein versus plant protein. While plant-based diets are often recommended for their anti-inflammatory and cardiovascular benefits, they may lack sufficient leucine to activate anabolic signaling pathways in certain tissues. It remains unclear whether supplementing plant-based protein with free leucine can achieve the same biological responses as animal protein ingestion.

The trial includes three study arms: (1) a smoothie containing only plant-based protein, (2) a smoothie containing animal-based protein, and (3) a plant-based smoothie with added free leucine. Each smoothie is isocaloric and matched in macronutrient content, differing only in protein source and leucine content. All meals will be prepared and administered under controlled conditions at the Clinical and Translational Research Center (CTRC) at UPMC Montefiore.

Participants will be healthy adults without chronic illnesses or recent infections, aged 18 years and older. Each participant will complete all three study visits in a randomized order, with a minimum 3-day washout period between visits. At each visit, participants will be asked to fast for 10 hours overnight before arriving at the CTRC in the morning. Upon arrival, fasting blood will be collected, followed by consumption of the assigned test smoothie. Additional blood samples will be collected at 1 and 3 hours post-consumption to evaluate postprandial responses.

Blood samples will be analyzed for:

Circulating amino acid levels (primary: leucine)

mTORC1 signaling activity in peripheral blood mononuclear cells (PBMCs), assessed via phosphorylation of S6 kinase (pS6)

Inflammatory and immune signaling markers (e.g., IL-6, NF-κB)

Exploratory transcriptomic profiling and broader amino acid analysis if resources allow

The main hypotheses are:

Animal-based protein will induce higher postprandial leucine levels and stronger mTORC1 activation than plant-based protein.

Supplementation of free leucine in the plant-based smoothie will mimic the biological effects of the animal protein smoothie on immune/metabolic responses.

The findings from this study could provide novel insights into how different dietary proteins modulate nutrient sensing and immune pathways. If plant-based protein supplemented with leucine proves to mimic the effects of animal protein, this could support more sustainable and heart-healthy dietary recommendations without compromising key metabolic functions.

Ultimately, this study will contribute to a deeper understanding of the nutritional regulation of mTOR and inflammation in humans and may inform future dietary interventions aimed at preventing or mitigating chronic cardiometabolic diseases such as atherosclerosis and diabetes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiometabolic Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This is a randomized crossover study in which each participant receives all three interventions (animal protein smoothie, plant protein smoothie, plant protein smoothie with leucine) on separate study visits in a randomized order. This design allows within-subject comparisons of postprandial responses.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Animal → Plant → Plant+Leucine

Participants in this arm will receive the animal-based protein smoothie during their first visit, the plant-based protein smoothie during their second visit, and the plant-based protein smoothie with added leucine during their third visit. All study visits follow the same protocol, including fasting, blood draws, and postprandial assessments.

Group Type EXPERIMENTAL

Animal-Based Protein Smoothie

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from high-quality animal-based protein, such as whey protein isolate or pasteurized egg whites. It is designed to evaluate the postprandial metabolic and immune response to animal-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Plant-Based Protein Smoothie

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, such as pea or rice protein isolate. It is designed to evaluate the postprandial metabolic and immune response to plant-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Plant-Based Protein Smoothie with Leucine

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, using sources such as pea or rice protein isolate. In addition, it is supplemented with pharmaceutical-grade leucine to match the leucine content typically found in animal-based protein sources. The smoothie is designed to assess whether leucine supplementation can modulate the postprandial metabolic and immune response to plant-derived protein. It is prepared in a food-safe certified kitchen and consumed after an overnight fast to maintain consistency across study conditions.

Plant-Based → Plant-Based with Leucine → Animal-Based

Participants in this arm will receive the plant-based protein smoothie first, the plant-based protein smoothie with leucine second, and the animal-based protein smoothie third. All clinical procedures are the same across visits.

Group Type EXPERIMENTAL

Animal-Based Protein Smoothie

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from high-quality animal-based protein, such as whey protein isolate or pasteurized egg whites. It is designed to evaluate the postprandial metabolic and immune response to animal-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Plant-Based Protein Smoothie

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, such as pea or rice protein isolate. It is designed to evaluate the postprandial metabolic and immune response to plant-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Plant-Based Protein Smoothie with Leucine

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, using sources such as pea or rice protein isolate. In addition, it is supplemented with pharmaceutical-grade leucine to match the leucine content typically found in animal-based protein sources. The smoothie is designed to assess whether leucine supplementation can modulate the postprandial metabolic and immune response to plant-derived protein. It is prepared in a food-safe certified kitchen and consumed after an overnight fast to maintain consistency across study conditions.

Plant-Based with Leucine → Animal-Based → Plant-Based

Participants in this arm will receive the plant-based protein smoothie with leucine at their first visit, the animal-based smoothie second, and the plant-based protein smoothie third. The same procedures will be followed at each visit.

Group Type EXPERIMENTAL

Animal-Based Protein Smoothie

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from high-quality animal-based protein, such as whey protein isolate or pasteurized egg whites. It is designed to evaluate the postprandial metabolic and immune response to animal-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Plant-Based Protein Smoothie

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, such as pea or rice protein isolate. It is designed to evaluate the postprandial metabolic and immune response to plant-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Plant-Based Protein Smoothie with Leucine

Intervention Type DIETARY_SUPPLEMENT

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, using sources such as pea or rice protein isolate. In addition, it is supplemented with pharmaceutical-grade leucine to match the leucine content typically found in animal-based protein sources. The smoothie is designed to assess whether leucine supplementation can modulate the postprandial metabolic and immune response to plant-derived protein. It is prepared in a food-safe certified kitchen and consumed after an overnight fast to maintain consistency across study conditions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Animal-Based Protein Smoothie

This smoothie is formulated to deliver 50% of its total caloric content from high-quality animal-based protein, such as whey protein isolate or pasteurized egg whites. It is designed to evaluate the postprandial metabolic and immune response to animal-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Intervention Type DIETARY_SUPPLEMENT

Plant-Based Protein Smoothie

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, such as pea or rice protein isolate. It is designed to evaluate the postprandial metabolic and immune response to plant-derived protein sources. The smoothie does not contain any added free amino acids and is prepared in a food-safe certified kitchen under standardized conditions. All participants consume the smoothie after an overnight fast to ensure consistency in metabolic assessment.

Intervention Type DIETARY_SUPPLEMENT

Plant-Based Protein Smoothie with Leucine

This smoothie is formulated to deliver 50% of its total caloric content from plant-based protein, using sources such as pea or rice protein isolate. In addition, it is supplemented with pharmaceutical-grade leucine to match the leucine content typically found in animal-based protein sources. The smoothie is designed to assess whether leucine supplementation can modulate the postprandial metabolic and immune response to plant-derived protein. It is prepared in a food-safe certified kitchen and consumed after an overnight fast to maintain consistency across study conditions.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18-65 years
2. BMI 18.5-29.9 kg/m²
3. Generally healthy, without known chronic illness and/or treatment with chronic medications
4. Willing to comply with dietary restrictions and study procedures
5. Not currently following a prescribed or restrictive diet (for example, vegan, ketogenic or high-protein regimen) or regularly taking high-protein supplements

Exclusion Criteria

1. History of cardiovascular disease, diabetes, or autoimmune disorders
2. Active use of anti-inflammatory, immunomodulatory, or lipid-lowering medications
3. Renal or hepatic dysfunction
4. Pregnancy or breastfeeding
5. Allergies or intolerances to components of study meals. A list of the smoothie ingredients will be sent to the potential participant with the mailing of the consent form
6. Participation in another interventional study within the last 30 days
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pittsburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Ajam

Postdoctoral Associate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Babak Razani, MD-PhD

Role: STUDY_DIRECTOR

University of Pittsburgh

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UPMC Montefiore - Clinical and Translational Research Center (CTRC)

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ali Ajam, MD

Role: CONTACT

412-512-1044

Babak Razani, MD-PhD

Role: CONTACT

412-648-7496

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY25060010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.